This is the second edition in my “farewell to oral meds” articles, welcome to “Lurasidone.” (Trade Name: Latuda)
This is The Frontier Psychiatrists Newsletter. It is a one-person daily health-related adventure in writing. Please subscribe—the once-a-day articles are almost always free, but older some real gems that might change your life1 are locked away behind a paywall! What is in there? Could your life be better? Yes2. However, without taking the step3 of subscribing, you will never know.
It is worth noting for new readers that this daily newsletter often uses satire because it is more fun. Also, I have stalkers—yes, I do. This is common for doctors, particularly psychiatrists. My stalkers have a limited grasp of sarcasm. So that tone? It is my shield, more or less.
All of the standard caveats about atypical antipsychotics aside, Lursaidone has some differences with other agents…
From a safety and efficacy standpoint, Lurisdone has FDA approval for treating bipol…